Goodpath Secures $18M to Expand AI-Driven Healthcare Platform

September 12, 2025
Goodpath has raised $18 million in Series A funding, led by MassMutual Ventures, to enhance its AI-driven care model for chronic conditions.

Goodpath has raised $18 million in Series A funding, led by MassMutual Ventures, announced in a press release. The funding will be used to accelerate the expansion of its AI-driven, clinically-validated care model, which integrates treatment for chronic conditions such as weight management, musculoskeletal pain, sleep, digestive health, mental health, diabetes, and cancer survivorship.

Co-founded by CEO Bill Gianoukos and Dr. Akl Fahed, Goodpath aims to address the fragmented nature of chronic condition care in the U.S. by providing a seamless, integrative care experience. The platform leverages a learning care model powered by a growing dataset of over 4.5 million real-world data points, enabling it to improve recommendations and tailor care pathways to individual needs.

The new funding will also support the development of outcome prediction models, AI-led personalization tools, and expanded product capabilities, including prescribing and complex care navigation. Goodpath's approach aims to deliver cost savings for employers and improved health outcomes for their workforces.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

AI Funding News Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Funding

09/12
Demand AI Group Secures $2.5 Million for Global Expansion
09/12
Eightco Holdings Completes $270 Million Private Placement for Worldcoin Strategy
09/12
Capacity Acquires KLaunch to Enhance Conversational AI
09/12
iCIMS Acquires Apli to Enhance AI Recruitment Platform
09/12
Labs Investor Group Plans $1.1 Billion in New Funds for 2026

More from: Life Sciences

09/12
Imaging Endpoints Files Patent for AI-Enhanced Imaging Review System
09/12
Homecare Homebase and Element5 Partner to Enhance Post-Acute Care with AI
09/12
University of Utah Partners with HPE and NVIDIA for AI Research
09/12
uLab and Biolux Partner to Enhance Clear Aligner Therapy
09/12
Eko Health's AI Stethoscope Enhances Heart Disease Detection

Subscribe to AI Funding Brief

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You May Also Like